Xeris Biopharma Shares Jump 29% After Q3 Results Top Estimates
Xeris Biopharma shares surged 29% after its third-quarter results topped estimates.
Related stories
Sisecam Reports Q3 Loss of 295.3 Million Lira
Sisecam reported a Q3 loss of 295.3 million lira, compared with net profit of 1.9 billion lira a year earlier.
M impact | EQUITY | Nov 05, 2026, 03:18 PM UTC
Era Media Sejahtera Proposes Rights Issue of Up to 154,777,820,720 Shares
M impact | EQUITY | Nov 05, 2026, 03:18 PM UTC
Strategic Education Reports Quarterly Results for Quarter Ended September 30
The report covers Strategic Education’s results for the quarter ended September 30. The supplied body provides no financial figures.
M impact | EQUITY | Nov 05, 2026, 03:17 PM UTC
Amylyx Pharmaceuticals Reports Quarterly Results
Amylyx Pharmaceuticals reported results for the quarter ended September 30; the available report does not specify the figures.
M impact | EQUITY | Nov 05, 2026, 03:17 PM UTC
Nasdaq slides as investors reassess AI spending
The Nasdaq slid, with investors reassessing the AI spending boom.
M impact | EQUITY | Nov 05, 2026, 03:17 PM UTC
Planet Fitness Reports Quarterly Results
Planet Fitness reported results for the quarter ended September 30; no figures are provided.
M impact | EQUITY | Nov 05, 2026, 03:17 PM UTC